New drugs in the treatment of non-small cell lung cancer

This publication has 32 references indexed in Scilit:

• Phase II study of pirarubicin in advanced non-small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1989
• 4-Ipomeanol: A Novel Investigational New Drug for Lung Cancer
  JNCI Journal of the National Cancer Institute, 1989
• Phase I Trial of Trimetrexate Glucuronate on a Five-Day Bolus Schedule: Clinical Pharmacology and Pharmacodynamics
  JNCI Journal of the National Cancer Institute, 1989
• Chronic Administration of Lonidamine in Untreated Non-Small Cell Lung Cancer of Stage III M0–1
  Chemotherapy, 1989
• Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung
  European Journal of Cancer and Clinical Oncology, 1984
• Phase I and Clinical Pharmacologic Evaluation of Lonidamine in Patients with Advanced Cancer
  Oncology, 1984
• Promotion of microtubule assembly in vitro by taxol
  Nature, 1979
• Effects of 4-Ipomeanol, a Product from Mold-Damaged Sweet Potatoes, on the Bovine Lung
  Veterinary Pathology, 1978
• Role of metabolic activation in the pathogenesis of chemically induced pulmonary disease: mechanism of action of the lung-toxic furan, 4-ipomeanol.
  Environmental Health Perspectives, 1976
• Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
  Journal of the American Chemical Society, 1971